 | Up a level |
Journal Article
Ferreira, Arlindo R., Ponde, Noam, Lambertini, Matteo, Maurer, Christian, Martel, Samuel, Costa, Luis and De Azambuja, Evandro (2020). Association between pertuzumab (P) induced diarrhea and skin rash and survival outcomes in patients (pts) with HER2-positive metastatic breast cancer enrolled in the CLEOPATRA trial. Cancer Res., 80 (4). PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445
Martel, Samuel, Lambertini, Matteo, Agbor-Tarh, Dominique, Ponde, Noam Falbel, Gombos, Andrea, Paterson, Vicki, Hilbers, Florentine 
ORCID: 0000-0002-6764-3102, Korde, Larissa, Manukyants, Anna, Dueck, Amylou C., Maurer, Christian, Piccart-Gebhart, Martine J., Moreno-Aspitia, Alvaro, Desmedt, Christine ORCID: 0000-0002-5223-5579, Di Cosimo, Serena and De Azambuja, Evandro
(2018).
Impact of body mass index (BMI) and weight change after treatment in patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Secondary analysis of the ALTTO BIG 2-06 trial.
J. Clin. Oncol., 36 (15).
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Martel, Samuel, Maurer, Christian, Lambertini, Matteo ORCID: 0000-0003-1797-5296, Ponde, Noam and De Azambuja, Evandro
(2017).
Breast cancer treatment-induced cardiotoxicity.
Expert Opin. Drug Saf., 16 (9).
S. 1021 - 1039.
ABINGDON:
TAYLOR & FRANCIS LTD.
ISSN 1744-764X
Poggio, Francesca, Bruzzone, Marco, Ceppi, Marcello, Conte, Benedetta, Martel, Samuel, Maurer, Christian, Tagliamento, Marco ORCID: 0000-0001-7461-023X, Viglietti, Giulia, Del Mastro, Lucia ORCID: 0000-0002-9546-5841, De Azambuja, Evandro and Lambertini, Matteo
(2018).
PARP inhibitors (PARPi) for the treatment of BRCA-mutated HER2negative (HER2-) metastatic breast cancer (MBC) patients: A systematic review and meta-analysis.
J. Clin. Oncol., 36 (15).
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755